article thumbnail

Article EMA Thank You EMA publishes first electronic Product Information as pilot progresses

Agency IQ

readability of package leaflet, patient engagement). Summary of Product Characteristics and Package Leaflet), recommending that sponsors and regulators “explore the use of electronic media” to provide product information “in the future”. See also Article 11 of Directive 2001/83/EC.)

article thumbnail

Article EMA Thank You The vote is in: The European Parliament has adopted the compromise pharmaceutical legislation

Agency IQ

Directive 2001/83/EC and Regulation (EC) No 726/2004. Additionally, reform package included revisions of the regulations for pediatric medicines and orphan drugs. Generally, all MEPs supported the package in its current form, with political affiliations shaping the provisions each highlighted. citizens; 2.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Article EMA Thank You New MHRA Windsor Framework documents guide post-Brexit flow of medicines for U.K., Great Britain, and the E.U.

Agency IQ

The document specifically notes that it applies to “medicinal products for human use intended to be placed on the market in Northern Ireland in accordance with Article 6 of Directive 2001/83/EC,” the current European pharmaceutical legislation. only” label can be affixed anywhere on the packaging. The FMD does not apply, but the “U.K.

article thumbnail

Article EMA Thank You The devil is in the details: a deep dive into the state of Notified Body designations

Agency IQ

There are two codes that all 49 Notified Bodies received designation to – devices with a measuring function (MDS 1010) and devices that require packaging/labeling (MDT 2011).

article thumbnail

Analysis Life Sciences Thank You The cost of artificially short expiration dates: Worsened shortages, higher costs and more waste

Agency IQ

In 2001, the American Medical Association (AMA) conducted a survey of relevant stakeholders – including PhRMA, the U.S. In some cases, manufacturers have determined that specific drug products have limited stability when the original packaging is opened. When such a situation is identified, it is noted in the product labeling.

Science 40
article thumbnail

Where is the promise for plant-based medicines? Part 2: Psilocybin 

Drug Discovery World

Within the debate, an e-petition was presented, which closed in February 2023 and received 11,824 signatures, and called on the government to reschedule psilocybin for medical research on untreatable conditions to Schedule II of the Misuse of Drugs Regulations 2001. million of the investment is dedicated to mental health research 7.

article thumbnail

Article EMA Thank You Commission proposes guidelines to flesh out the newly finalized Variations Regulation

Agency IQ

It applies to products with marketing authorizations according to Regulation (EC) No 726/2004 and Directive 2001/83/EC, but does not apply to the transfer of the marketing authorization from one holder to another. Chapter 4 of Directive 2001/83/EC allows Member States to recognize assessments from another E.U.